These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 38966504)

  • 1. Global Perspective on COVID-19 Therapies, Cardiovascular Outcomes, and Implications for Long COVID: A State-of-the-Art Review.
    Sarfraz A; Sarfraz Z; Bano S; Sarfraz M; Jaan A; Minhas A; Razzack AA; Patel G; Manish KC; Makkar SS; Garimella R; Pandav K; Almonte J; Paul T; Almonte T; Jimenez L; Pantoga JC; El Mazboudi N; Yatzkan G; Michel G; Michel J
    J Community Hosp Intern Med Perspect; 2024; 14(2):58-66. PubMed ID: 38966504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repurposing Immunomodulatory Therapies against Coronavirus Disease 2019 (COVID-19) in the Era of Cardiac Vigilance: A Systematic Review.
    Campbell CM; Guha A; Haque T; Neilan TG; Addison D
    J Clin Med; 2020 Sep; 9(9):. PubMed ID: 32932930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 Clinical Trials: A Primer for the Cardiovascular and Cardio-Oncology Communities.
    Ky B; Mann DL
    JACC CardioOncol; 2020 Jun; 2(2):254-269. PubMed ID: 32313885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 Clinical Trials: A Primer for the Cardiovascular and Cardio-Oncology Communities.
    Ky B; Mann DL
    JACC Basic Transl Sci; 2020 May; 5(5):501-517. PubMed ID: 32309679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physical interventions to interrupt or reduce the spread of respiratory viruses.
    Jefferson T; Del Mar CB; Dooley L; Ferroni E; Al-Ansary LA; Bawazeer GA; van Driel ML; Jones MA; Thorning S; Beller EM; Clark J; Hoffmann TC; Glasziou PP; Conly JM
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD006207. PubMed ID: 33215698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combating the Pandemic COVID-19: Clinical Trials, Therapies and Perspectives.
    Kotta S; Aldawsari HM; Badr-Eldin SM; Alhakamy NA; Md S; Nair AB; Deb PK
    Front Mol Biosci; 2020; 7():606393. PubMed ID: 33282914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influenza Vaccination to Reduce Cardiovascular Morbidity and Mortality in Patients With COVID-19: JACC State-of-the-Art Review.
    Behrouzi B; Araujo Campoverde MV; Liang K; Talbot HK; Bogoch II; McGeer A; Fröbert O; Loeb M; Vardeny O; Solomon SD; Udell JA
    J Am Coll Cardiol; 2020 Oct; 76(15):1777-1794. PubMed ID: 33032740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Approaching coronavirus disease 2019: Mechanisms of action of repurposed drugs with potential activity against SARS-CoV-2.
    Lisi L; Lacal PM; Barbaccia ML; Graziani G
    Biochem Pharmacol; 2020 Oct; 180():114169. PubMed ID: 32710969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physical interventions to interrupt or reduce the spread of respiratory viruses.
    Jefferson T; Dooley L; Ferroni E; Al-Ansary LA; van Driel ML; Bawazeer GA; Jones MA; Hoffmann TC; Clark J; Beller EM; Glasziou PP; Conly JM
    Cochrane Database Syst Rev; 2023 Jan; 1(1):CD006207. PubMed ID: 36715243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lessons Learned from Coronavirus Disease 2019 (COVID-19) Therapies: Critical Perspectives From the Infectious Diseases Society of America (IDSA) COVID-19 Treatment Guideline Panel.
    Bhimraj A; Morgan RL; Shumaker AH; Baden L; Cheng VC; Edwards KM; Gandhi RT; Gallagher JC; Muller WJ; O'Horo JC; Shoham S; Wollins DS; Falck-Ytter Y
    Clin Infect Dis; 2022 May; 74(9):1691-1695. PubMed ID: 34668008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementation of platform trials in the COVID-19 pandemic: A rapid review.
    Vanderbeek AM; Bliss JM; Yin Z; Yap C
    Contemp Clin Trials; 2022 Jan; 112():106625. PubMed ID: 34793985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of CTSA institutes and academic medical centers in facilitating preapproval access to investigational agents and devices during the COVID-19 pandemic.
    Gravelin M; Wright J; Holbein MEB; Berro M; Brown JS; Mashour GA; Weatherwax KJ
    J Clin Transl Sci; 2021 Feb; 5(1):e94. PubMed ID: 34192051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repurposed immunomodulatory drugs for Covid-19 in pre-ICu patients - mulTi-Arm Therapeutic study in pre-ICu patients admitted with Covid-19 - Repurposed Drugs (TACTIC-R): A structured summary of a study protocol for a randomised controlled trial.
    Kulkarni S; Fisk M; Kostapanos M; Banham-Hall E; Bond S; Hernan-Sancho E; Norton S; Cheriyan J; Cope A; Galloway J; Hall F; Jayne D; Wilkinson IB
    Trials; 2020 Jul; 21(1):626. PubMed ID: 32641154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of clinical trials evaluating cardiovascular therapies for Coronavirus Disease 2019 Registered on ClinicalTrials.gov: a cross sectional analysis.
    Varshney AS; Wang DE; Bhatt AS; Blood A; Sharkawi MA; Siddiqi HK; Vaduganathan M; Monteleone PP; Patel MR; Jones WS; Lopes RD; Mehra MR; Bhatt DL; Kochar A
    Am Heart J; 2021 Feb; 232():105-115. PubMed ID: 33121978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Scoping Insight on Potential Prophylactics, Vaccines and Therapeutic Weaponry for the Ongoing Novel Coronavirus (COVID-19) Pandemic- A Comprehensive Review.
    Dash P; Mohapatra S; Ghosh S; Nayak B
    Front Pharmacol; 2020; 11():590154. PubMed ID: 33815095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug repurposing for COVID-19: Approaches, challenges and promising candidates.
    Ng YL; Salim CK; Chu JJH
    Pharmacol Ther; 2021 Dec; 228():107930. PubMed ID: 34174275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNA Viruses, Pregnancy and Vaccination: Emerging Lessons from COVID-19 and Ebola Virus Disease.
    Dhanya CR; Shailaja A; Mary AS; Kandiyil SP; Savithri A; Lathakumari VS; Veettil JT; Vandanamthadathil JJ; Madhavan M
    Pathogens; 2022 Jul; 11(7):. PubMed ID: 35890044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic review and meta-analysis of cell therapy for COVID-19: global clinical trial landscape, published safety/efficacy outcomes, cell product manufacturing and clinical delivery.
    Couto PS; Al-Arawe N; Filgueiras IS; Fonseca DLM; Hinterseher I; Catar RA; Chinnadurai R; Bersenev A; Cabral-Marques O; Moll G; Verter F
    Front Immunol; 2023; 14():1200180. PubMed ID: 37415976
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.